Redhill Biopharma Ltd. - American Depositary Shares (RDHL)
5.9093
-0.0207 (-0.35%)
Redhill Biopharma is a biopharmaceutical company focused on the development and commercialization of innovative therapies for gastrointestinal diseases and other serious conditions
The company specializes in creating novel formulations and repurposing existing drugs to improve treatment outcomes for patients. Redhill is dedicated to addressing unmet medical needs through its robust pipeline of products, which includes both clinical-stage candidates and marketed drugs. By leveraging advanced scientific research and a strategic approach to drug development, Redhill aims to improve the lives of patients suffering from complex health issues.
RedHill Biopharma released study results showing opaganib's potential in treating Type 2 diabetes and obesity. The drug's ability to target sphingolipid metabolism could help prevent weight gain and improve glucose tolerance.
U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite turning lower on Thursday. The Dow traded up 0.25% to 37,900.45 while the NASDAQ fell 0.13% to 15,462.53. The S&P 500 also rose, gaining, 0.19% to 4,877.88.
U.S. stocks traded slightly higher midway through trading, with the Nasdaq Composite gaining around 0.2% on Thursday. The Dow traded up 0.06% to 37,829.32 while the NASDAQ rose 0.22% to 15,515.62. The S&P 500 also rose, gaining, 0.26% to 4,881.28.
Shares of Humana Inc. (NYSEHUM) fell sharply during Thursday’s session after the company reported fourth-quarter FY23 earnings and issued 2024 guidance.
U.S. stocks traded higher this morning, with the Dow Jones index gaining over 100 points on Thursday. Following the market opening Thursday, the Dow traded up 0.33% to 37,932.33 while the NASDAQ rose 0.37% to 15,538.69. The S&P 500 also rose, gaining, 0.40% to 4,887.88.
Shares of BlackBerry Limited (NYSEBB) fell sharply during Wednesday’s session after the company announced a proposed private offering of $160 million of convertible senior notes. BlackBerry shares tumbled 17.2% to $2.9387 on Wednesday.
Redhill Biopharma Ltd. shares are trading higher Wednesday after the company was granted a patent for a method for eradicating helicobacter pylori infections in patients regardless of body mass index.
